Internal Medicine Doctors in Loudon, TN Accepting Medicare
5 Internal Medicine doctors found. Showing 1 - 5
 Gabriel A Ojeda, MD Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 202 Dohi Dr, Loudon, TN 37774 Phone: 865-647-3520 Fax: 865-647-3529 |
Dr. James Joseph Acker I, Internal Medicine - Interventional Cardiology Medicare: Not Enrolled in Medicare Practice Location: 205 Todaly Cir, Loudon, TN 37774 Phone: 865-776-4071 |
Dr. Robert P Martyn, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 202 Dohi Dr, Loudon, TN 37774 Phone: 865-392-3400 Fax: 865-392-3449 |
Dr. Mohammad R Rahman, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 111 Clyde St, Loudon, TN 37774 Phone: 865-458-1554 Fax: 865-458-1762 |
Dr. Bipinchandra M. Patel, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 111 Clyde St, Loudon, TN 37774 Phone: 865-458-1554 Fax: 865-458-1762 |
News Archive
MD Anderson collaborates with Denali Therapeutics to advance novel therapies for neurodegenerative diseases
The University of Texas MD Anderson Cancer Center today announced a strategic research collaboration with Denali Therapeutics Inc. to develop novel therapies for Alzheimer's and other neurodegenerative diseases.
Study questions whether FDA too tough on online pharmacies
The Food and Drug Administration has warned people about the many dangers of buying medications from foreign pharmacies over the Internet. While some sites might offer high-quality medicines, there are plenty that sell bogus and potentially dangerous products. But a recent economic analysis suggests that while there's good reason for the safety warnings, the FDA's stance on the matter might go too far.
Mice put into "suspended animation" in U.S.
Researchers from the University of Washington and the Fred Hutchinson Cancer Research Centre in Seattle have placed mice in a state of near suspended animation, raising the possibility that in future hibernation could be induced in humans.
Experts provide insight into novel concepts and approaches for stroke rehabilitation
Stroke remains a leading cause of adult disability, and the global burden of stroke continues to grow with devastating consequences for patients, families, and caregivers.
Bayer's SAFYRAL oral contraceptive receives FDA approval
Bayer HealthCare Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved a new oral contraceptive (OC), SAFYRAL™ (drospirenone 3 mg/ ethinyl estradiol 30 mcg/ levomefolate calcium 451 mcg tablets and levomefolate calcium 451 mcg tablets). In women who choose an OC for birth control, SAFYRAL raises folate levels for the purpose of reducing the risk of rare neural tube defects (NTDs) in a pregnancy conceived while taking SAFYRAL or shortly after discontinuing it.
› Verified 5 days ago
Family Medicine
Internal Medicine
Pediatrics
Cardiovascular Disease
Orthopaedic Surgery